Neogen Corporation Common Stock, Value, Issued
Neogen Corporation (NEOG) had Common Stock, Value, Issued of $34.80 million as of 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-07-30
- 2026-05-31: Common Stock, Value, Issued $34.80M.
- 2026-02-28: Common Stock, Value, Issued $34.80M.
- 2025-11-30: Common Stock, Value, Issued $34.80M.
- 2025-08-31: Common Stock, Value, Issued $34.77M.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-05-31 | $34.80M 10-K · filed 2026-07-30 | |
| 2026-02-28 | $34.80M 10-Q · filed 2026-04-09 | |
| 2025-11-30 | $34.80M 10-Q · filed 2026-01-08 | |
| 2025-08-31 | $34.77M 10-Q · filed 2025-10-09 | |
| 2025-05-31 | $34.70M 10-K · filed 2026-07-30 | $34.73M 10-K · filed 2025-07-30 |
| 2025-02-28 | $34.73M 10-Q · filed 2025-04-09 | |
| 2024-11-30 | $34.71M 10-Q · filed 2025-01-15 | |
| 2024-08-31 | $34.67M 10-Q · filed 2024-10-10 | |
| 2024-05-31 | $34.66M 10-K · filed 2025-07-30 | |
| 2024-02-29 | $34.66M 10-Q · filed 2024-04-09 | |
| 2023-11-30 | $34.64M 10-Q · filed 2024-01-09 | |
| 2023-08-31 | $34.61M 10-Q · filed 2023-10-10 | |
| 2023-05-31 | $34.60M 10-K · filed 2024-07-30 | |
| 2023-02-28 | $34.59M 10-Q · filed 2023-04-04 | |
| 2022-11-30 | $34.58M 10-Q · filed 2023-01-09 | |
| 2022-08-31 | $17.25M 10-Q · filed 2022-09-30 | |
| 2022-05-31 | $17.25M 10-K · filed 2023-08-15 | |
| 2022-02-28 | $17.25M 10-Q · filed 2022-04-01 | |
| 2021-11-30 | $17.24M 10-Q · filed 2021-12-30 | |
| 2021-08-31 | $17.20M 10-Q · filed 2021-09-30 | |
| 2021-05-31 | $17.20M 10-K · filed 2022-07-27 | |
| 2021-02-28 | $8.56M 10-Q · filed 2021-03-31 | |
| 2020-11-30 | $8.52M 10-Q · filed 2020-12-29 | |
| 2020-08-31 | $8.49M 10-Q · filed 2020-09-30 | |
| 2020-05-31 | $16.94M 10-K · filed 2021-07-30 | $8.47M 10-K · filed 2020-07-30 |
| 2020-02-29 | $8.47M 10-Q · filed 2020-04-03 | |
| 2019-11-30 | $8.43M 10-Q · filed 2019-12-27 | |
| 2019-08-31 | $8.39M 10-Q · filed 2019-09-26 | |
| 2019-05-31 | $8.36M 10-K · filed 2020-07-30 | |
| 2019-02-28 | $8.34M 10-Q · filed 2019-03-29 | |
| 2018-11-30 | $8.33M 10-Q · filed 2018-12-28 | |
| 2018-08-31 | $8.32M 10-Q · filed 2018-10-05 | |
| 2018-05-31 | $8.28M 10-K · filed 2019-07-30 | |
| 2018-02-28 | $8.25M 10-Q · filed 2018-03-29 | |
| 2017-11-30 | $8.24M 10-Q · filed 2018-01-05 | |
| 2017-08-31 | $6.12M 10-Q · filed 2017-09-29 | |
| 2017-05-31 | $8.15M 10-K · filed 2018-07-27 | $6.11M 10-K · filed 2017-07-28 |
| 2017-02-28 | $6.10M 10-Q · filed 2017-03-31 | |
| 2016-11-30 | $6.08M 10-Q · filed 2016-12-29 | |
| 2016-08-31 | $6.03M 10-Q · filed 2016-09-30 | |
| 2016-05-31 | $6.01M 10-K · filed 2017-07-28 | |
| 2016-02-29 | $6.00M 10-Q · filed 2016-03-31 | |
| 2015-11-30 | $5.99M 10-Q · filed 2016-01-08 | |
| 2015-08-31 | $5.98M 10-Q · filed 2015-09-30 | |
| 2015-05-31 | $5.94M 10-K · filed 2016-07-29 | |
| 2015-02-28 | $5.93M 10-Q · filed 2015-04-01 | |
| 2014-11-30 | $5.91M 10-Q · filed 2014-12-30 | |
| 2014-08-31 | $5.91M 10-Q · filed 2014-09-30 | |
| 2014-05-31 | $5.88M 10-K · filed 2015-07-30 | |
| 2014-02-28 | $5.86M 10-Q · filed 2014-04-04 | |
| 2013-11-30 | $5.86M 10-Q · filed 2014-01-09 | |
| 2013-08-31 | $3.88M 10-Q · filed 2013-09-30 | |
| 2013-05-31 | $5.77M 10-K · filed 2014-07-30 | $3.85M 10-K · filed 2013-07-30 |
| 2013-02-28 | $3.83M 10-Q · filed 2013-03-28 | |
| 2012-11-30 | $3.82M 10-Q · filed 2012-12-28 | |
| 2012-08-31 | $3.81M 10-Q · filed 2012-09-28 | |
| 2012-05-31 | $3.78M 10-K · filed 2013-07-30 | |
| 2012-02-29 | $3.77M 10-Q · filed 2012-03-30 | |
| 2011-11-30 | $3.76M 10-Q · filed 2011-12-30 | |
| 2011-08-31 | $3.74M 10-Q · filed 2011-09-30 | |
| 2011-05-31 | $3.73M 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |